News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
Proposed Prescription Drug User Fee Act VII…
Biotechnology Innovation Organization (BIO) Chief Scientific Officer, E. Cartier Esham issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VII performance goals letter: “The Prescription Drug User Fee…
Biden Drug Plan Adds Barriers to Seniors…
President Joe Biden today announced a slew of drug pricing reforms, including changes that would radically alter the widely successful Medicare program for seniors and people with disabilities. Rich Masters, BIO’s Chief Public Affairs and Advocacy…
BIO Announces 2021 Start-up Stadium Winner:…
Annual competition takes place during BIO’s International Convention
Letters, Testimony, & Comments
Congressional Letter to Administration on…
As you know, several challenges facing the agriculture industry and our communities have emerged or intensified in recent years. Zoonotic disease, climate change, and a growing global population require us to consider new solutions to protect our…
BIO Supporting Oxitec’s Experimental Use Permit …
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on the receipt of an application, 93167-EUP-2, from Oxitec Ltd requesting to amend and…
BIO Signs Letter to House Leadership on Need to…
The undersigned organizations write to encourage policymakers to remove provisions in the Build Back Better Act that would curtail the effectiveness of Qualified Small Business Stock (QSBS) in incentivizing investment in innovative small businesses…
Amicus Briefs
BIO Files Amicus Brief in Petition for a Writ of…
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that…
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
Blog Posts
Placeholder Image
October 18, 2021
By Danielle Davis, MSW  Inclusion is one of Gilead’s core values, and it not only guides how our employees work together, but also supports our commitment to eliminating health and healthcare disparities. Integrating…
Escaping the Food Allergy Prison
October 12, 2021
Every three minutes in the United States, an allergic reaction to foods sends someone to the emergency room. Today, we explore what life is like when you must avoid certain foods. But we also learn that there is hope…
Patient
October 14, 2021
The pandemic has heightened the need to advance health equity and, at Amgen, we continue to build upon our work to advance policies and practices in support of achieving health equity so that all people…